TVGN – tevogen bio holdings inc. (US:NASDAQ)
Stock Stats
News
Tevogen Bio CEO Named to NJBIZ 2025 Health Care Power List as Company Advances Commercialization; Reaffirms Timeframe on Previously Announced Forecast
Tevogen Bio Appoints David E. Banko as Global Head of Government Affairs and Patient Access, Advances Commercialization Plan
Tevogen Bio Holdings Inc. (NASDAQ: TVGN) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO [Yahoo! Finance]
Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO
Form 10-K Tevogen Bio Holdings For: Dec 31
Form NT 10-K Tevogen Bio Holdings For: Dec 31
Form 4 Tevogen Bio Holdings For: Mar 12 Filed by: Flomenberg Neal
Form 4 Tevogen Bio Holdings For: Mar 07 Filed by: Flomenberg Neal
Form 4 Tevogen Bio Holdings For: Mar 04 Filed by: Flomenberg Neal
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.